SFO
AMGN icon

Stokes Family Office’s Amgen AMGN Stock Holding History

Stokes Family Office’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Sell
5,143
-623
-11% -$213K 0.22% 92
2026
Q1 		$2.03M Sell
5,766
-642
-10% -$229K 0.21% 94
2025
Q4 		$2.1M Buy
6,408
+2,372
+59% +$752K 0.19% 91
2025
Q3 		$1.14M Buy
4,036
+1,419
+54% +$412K 0.11% 124
2025
Q2 		$731K Buy
2,617
+13
+0.5% +$3.68K 0.08% 133
2025
Q1 		$811K Sell
2,604
-1,500
-37% -$443K 0.09% 129
2024
Q4 		$1.07M Buy
4,104
+2,218
+118% +$658K 0.11% 119
2024
Q3 		$608K Sell
1,886
-25
-1% -$8.18K 0.07% 140
2024
Q2 		$597K Buy
1,911
+136
+8% +$40K 0.07% 142
2024
Q1 		$505K Buy
1,775
+44
+3% +$12.9K 0.06% 145
2023
Q4 		$498K Sell
1,731
-5,219
-75% -$1.42M 0.07% 142
2023
Q3 		$1.87M Buy
6,950
+1,345
+24% +$336K 0.22% 87
2023
Q2 		$1.24M Sell
5,605
-726
-11% -$168K 0.14% 112
2023
Q1 		$1.53M Sell
6,331
-1,148
-15% -$282K 0.19% 91
2022
Q4 		$1.96M Buy
7,479
+1,148
+18% +$308K 0.25% 74
2022
Q3 		$1.43M Sell
6,331
-6
-0.1% -$1.45K 0.2% 87
2022
Q2 		$1.54M Buy
6,337
+583
+10% +$143K 0.21% 86
2022
Q1 		$1.39M Buy
5,754
+1,946
+51% +$447K 0.18% 85
2021
Q4 		$857K Buy
3,808
+1,534
+67% +$324K 0.11% 116
2021
Q3 		$484K Buy
2,274
+116
+5% +$26.7K 0.07% 148
2021
Q2 		$526K Buy
2,158
+43
+2% +$10.6K 0.07% 137
2021
Q1 		$551K Buy
2,115
+36
+2% +$8.59K 0.09% 128
2020
Q4 		$478K Sell
2,079
-67
-3% -$15.4K 0.09% 114
2020
Q3 		$545K Sell
2,146
-546
-20% -$135K 0.12% 101
2020
Q2 		$635K Buy
2,692
+128
+5% +$29.2K 0.16% 93
2020
Q1 		$520K Buy
2,564
+828
+48% +$181K 0.14% 93
2019
Q4 		$419K Buy
+1,736
New +$383K 0.09% 102

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Stokes Family Office's AMGN Position: Q2 2026 in Review

Stokes Family Office reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $213K and leaving 5,143 shares worth $1.86M. The position accounts for 0.22% of the portfolio, ranked #92.

Stokes Family Office first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.1M in Q4 2025. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Stokes Family Office held 5,143 shares of Amgen worth $1.86M as of Q2 2026.
  • Stokes Family Office sold 623 Amgen shares in Q2 2026, an estimated $213K.
  • Amgen made up 0.22% of Stokes Family Office's portfolio in Q2 2026, its #92 holding.
  • Stokes Family Office first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Stokes Family Office's Amgen position peaked at $2.1M in Q4 2025.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.